Southeast Asia as a region of new pharmaceutical development

 
PIIS032150750018300-2-1
DOI10.31857/S032150750018300-2
Publication type Article
Status Published
Authors
Occupation: Research Fellow
Affiliation: Lomonosov Moscow State University, RANEPA
Address: Russian Federation,
Occupation: Student
Affiliation: Lomonosov Moscow State University
Address: 1, Leninskie Gory, Moscow, 119234
Journal nameAsia and Africa Today
EditionIssue 1
Pages62-70
Abstract

The article is dedicatedto the geographical analysis of the pharmaceutical industry in the countries of Southeast Asia, a region that has undergone serious changes over the past twenty years in the context of fierce competition on the international drug market. It was revealed that initially the development of pharmaceutical industry in the region took place under the influence of world multinational corporations, the production of medicines was focused exclusively on an external consumer and had an isolated spatial pattern. Subsidiariesof big pharmaceutical TNCs were located in such a way as to gain a competitive advantage in the form of cheaper labour and, at the same time, to minimize transaction costs for transporting locally produced medicines directly to the points of sale. Subsequently, the growth in the paying capacity of the local population led to the formation of a stable, albeit unevenly distributed intraregional demand, with a high potential for further expansion.Therefore, today the development of pharmaceutical industry in the countries of Southeast Asia is characterised as multi-scaled. As global value chains in the industry become more complex and advanced, there is a steady trend of a gradual deepening of intraregional ties.The countries of Southeast Asia still differ significantly in terms of the degree of maturity of the national pharmaceutical industry and domestic drug markets.These both criteria were used as the basic ones to create the typology of the countries of Southeast Asia according to the level and type of development of their pharmaceutical industry.

KeywordsSoutheast Asia, pharmaceutical industry, drug production, pharmaceutical market
Received21.06.2021
Publication date28.01.2022
Number of characters28497
Cite  
100 rub.
When subscribing to an article or issue, the user can download PDF, evaluate the publication or contact the author. Need to register.

Number of purchasers: 0, views: 473

Readers community rating: votes 0

1. Mendoza R.L. 2009. Is It Really Medicine? The Traditional and Alternative Medicine Act and Informal Health Economy in the Philippines. Asia Pacific Journal of Public Health. Vol. 21, № 3, pp. 333-345.

2. Banerjee M. 2002. Public Policy and Ayurveda: Modernising a Great Tradition. Economic and Political Weekly. Vol. 3, № 12, pp. 1136-1146.

3. GorkinA. P., Smirnyagin L. V.1973. About the factors and conditions of the location of the capitalist industry. Bulletin of the Russian Academy of Sciences. Geography series. № 1, pp. 68-75. (In Russ.)

4. Wages and working time statistics (COND). ILOSTAT. https://ilostat.ilo.org/data/ (accessed 16.02.2021)

5. Wiart C. Medicinal plants of Southeast Asia. Petaling Jaya: Prentice Hall, 2002, 395 p.

6. Oyen L. P. A., Nguyen Xuan Dung Plant Resources of South-East Asia. Leiden: Backhuys Publishers, 1999, 280 p.

7. Astutik S., Pretzsch J., Kimengsi N. 2019. Asian Medicinal Plants’ Production and Utilization Potentials: A Review. Sustainabi-lity. Vol. 11, pp. 5482-5535.

8. North D.C. Institutions and the Performance of Economies over Time. Handbook of New Institutional Economics. Heidelberg: Springer, 2008, pp. 21-30.

9. Podgornev P.V. 2016. Spatial structure of pharmaceutical industry in the postindustrial era. PhD (Geography) dissertation. Moscow. 190 p. (In Russ.)

Система Orphus

Loading...
Up